To produce a new drug or even a new vaccine, different steps are needed until reaching the final stage.
One of these steps, essential when it comes to ensuring that the study is completed successfully, is the Clinical Trials. They are made with voluntary people, who receive experimental treatments to be able to evaluate and observe the reactions and effects caused in humans.
To improve this process of triage and selection of volunteers, the pharmaceutical industry is already considering the use of artificial intelligence programs, capable of finding the ideal profile of each person who wants to participate in the creation of new medicines and vaccines.
This is the Canaltech Podcast, published from Tuesday to Saturday, at 7 am on our website and on podcast aggregators.
Meet Porta 101.
Enter Canaltech’s social networks by searching for @Canaltech in all of them.
Get in touch by our email: [email protected]
Enter no Canaltech Offers.
This episode was scripted and hosted by Gustavo Minari. The program also featured reports by Alveni Lisboa, Igor Almenara, Victor Carvalho and Vinícius Moschen. Edition by Natália Improta. The audio review is by Gabriel Rimi and Mari Capetinga. The soundtrack is a creation of Guilherme Zomer and the cover of this program is made by Erick Teixeira.
